A Comparative Analysis to Determine the Anti-Hypertensive Effect of Olmesartan Medoxomil and Enalapril

Journal Title: International Journal of Medical Research Professionals - Year 2018, Vol 4, Issue 1

Abstract

Background: The industrial revolution, development and adoption of western life style have made hypertension a significant health problem in India and thus have adversely affected the cardiovascular haemodynamics. Olmesartan medoxomil, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract. Olmesartan is a selective AT1 subtype angiotensin II receptor antagonist. The aim of the present study is to determine the antihypertensive effect of olmesartan medoxomil and enalapril. Materials and Methods: The present prospective study was conducted in the medicine department of Rajindra Hospital, Patiala. All the patients reporting to the OPD of the department whether new hypertensive or previously suffering from Stage I or Stage II hypertension were included in the study. 50 patients were put on Olmesartan and 50 on Enalapril for the treatment of hypertension. All the data obtained was arranged in a tabulated form and analysed using SPSS software. Student t test was used a test for significance and p value of less than 0.05 was considered significant. Results: In group A (Olmesartan), 8 patients were in the age group 20-39 years, 24 patients were in the age group 40-59, 15 patients were in the age group 60-79, 3 patients were in the age group ≥80. In group B (Enalapril), 7(14%) patients were in the range of 45-54 kg, 16(32%) kg were in the range of 55-64 kg There was observed marked fall in SBP (mm Hg) with drug therapy in both groups. In group A (Olmesartan), the mean SBP (mm Hg) at the beginning of trial, at 4 weeks and at 8weeks was 162 ± 6.37, 152.2 ± 4.63 and 149.16 ± 5.62 respectively and the fall in SBP (mm Hg) with the treatment was statistically significant (p <0.05). Conclusion: On long term basis both the drugs are equally effective but immediate effect is seen by olmesartan.

Authors and Affiliations

Parminderpal Singh, Dr. Kiranjit, Shabdeep Kaur, Husan Pal

Keywords

Related Articles

Risk Factors Potentiating Substance Abuse among Saudi Females: A Case Control Study

Introduction: For controlling the substance use issue, it is important to have a good knowledge of risk predisposing an individual towards substance use. The risk factors potentiating substance use among Saudi women are...

Assessment of Knowledge, Attitudes and Practices Toward Prevention of Hepatitis B Virus Infection Among Medical Students in Hail Region, Saudi Arabia

Objective: To assess the knowledge regarding symptoms, risk factors and prevention of hepatitis B virus infection among medical students in Hail, Saudi Arabia. Methods: A cross-sectional study was conducted at the facult...

Need of Anti-Glaucoma Drug Following Nd-YAG Laser Capsulotomy

Objective: Study to evaluate the need of an intra-ocular pressure (IOP) lowering topical agent after Neodymium-Yttrium Aluminum Garnet (Nd-YAG) laser capsulotomy. Methods: 120 patients with mild to moderate posterior cap...

General Anxiety Disorders among Celiac Disease Patients in Aseer Region of Saudi Arabia

To evaluate the association between celiac disease and specific anxiety and depressive disorders and to identify potential common Pathogenetic links and know to what extend celiac can effect on the life of people who suf...

Comparative Study of Surgical Outcome in Case of Primary Pterygium By Bare Sclera Excision & Conj. Autografting

Aim: To evaluate and analyze the surgical outcome of Simple pterygium excision (Bare sclera method) and Conjunctival Autografting (CAG). Design: Prospective Randomized control trial, hospital based study. Materials and M...

Download PDF file
  • EP ID EP531141
  • DOI 10.21276/ijmrp.2018.4.1.120
  • Views 60
  • Downloads 0

How To Cite

Parminderpal Singh, Dr. Kiranjit, Shabdeep Kaur, Husan Pal (2018). A Comparative Analysis to Determine the Anti-Hypertensive Effect of Olmesartan Medoxomil and Enalapril. International Journal of Medical Research Professionals, 4(1), 559-562. https://europub.co.uk/articles/-A-531141